Oncimmune Holdings PLC - ESG Rating & Company Profile powered by AI
This report of Oncimmune Holdings PLC was assembled by All Street Sevva using leading machine learning. The article contains a Q&A table for Oncimmune Holdings PLC. The SDG score for Oncimmune Holdings PLC represents its transparency towards the United Nations SDGs.
Oncimmune Holdings PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 5.3, social score of 1.6 and governance score of 6.0.
4.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 910 | Vaxcyte Inc | 4.4 | High |
| 910 | Yield10 Bioscience Inc | 4.4 | High |
| 951 | Oncimmune Holdings PLC | 4.3 | High |
| 951 | Cerecor Inc | 4.3 | High |
| 951 | Allergy Therapeutics PLC | 4.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Oncimmune Holdings PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Oncimmune Holdings PLC report the average age of the workforce?
Sign up for free to unlockDoes Oncimmune Holdings PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Oncimmune Holdings PLC offer flexible work?
Sign up for free to unlockDoes Oncimmune Holdings PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oncimmune Holdings PLC conduct supply chain audits?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oncimmune Holdings PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose water use targets?
Sign up for free to unlockDoes Oncimmune Holdings PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Oncimmune Holdings PLC have a product recall in the last two years?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Oncimmune Holdings PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oncimmune Holdings PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose parental leave metrics?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oncimmune Holdings PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oncimmune Holdings PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oncimmune Holdings PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose its waste policy?
Sign up for free to unlockDoes Oncimmune Holdings PLC report according to TCFD requirements?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose energy use targets?
Sign up for free to unlockDoes Oncimmune Holdings PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oncimmune Holdings PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oncimmune Holdings PLC
These potential risks are based on the size, segment and geographies of the company.
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.